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Calf health treatment protocols, compliance and economic impact: 
Northern New York research results
by Kimberley Morrill
Throughout 2018, the Northern 
New York Regional Ag team conducted 
research to determine protocol 
compliance for calfhood illnesses 
on Northern New York dairy farms, 
determine the treatment cost 
associated with calfhood illness 
and to bring awareness to antibiotic 
stewardship to increase consumer 
confidence in our food supply.
Farms were selected based on three 
criteria: 
1  Having written youngstock 
treatment protocols for respiratory 
and scours 
2  Having written or electronic 
youngstock treatment records that 
include: animal ID, reason for 
treatment, date of treatment, drug 
used and dosage
3  Allowing access to protocols and 
treatment records 
Treatment protocols were collected 
from all participating farms to compare 
to actual treatment records and 
determine if an animal was treated per 
protocol. Animals were classified as not 
on protocol for the following reasons: if 
the drug listed on the treatment record 
did not match the drug listed on the 
written farm protocol, if the treatment 
was not provided for the full duration 
as written on the protocol, and if the 
correct dosage of the drug was not 
provided.
Treatment records (paper and/
or electronic) were collected from 
all farms. Records were reviewed 
for protocol compliance, to evaluate 
the total number and percentage 
of youngstock treated per farm, 
the number and percentage of pre-
weaned heifers treated per farm, and 
the number of times an individual 
animal was treated over the eight-
Illness n Mean SD Low High
Pneumonia 4304 82.76 65.12 0 626
Scours 471 13.05 10.52 0 104
Metaphylaxis 823 73.24 20.34 0 112
Navel 365 12.19 12.19 3 73
Other1 278 209 73.95 93 444
Overall 6241 77.74 67.76 0 626
TABLE 1 
Average age (days) at onset of event by illness type
1Other includes: bloat, joint-ill, pink eye, ear infection, and arthritis.
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month period of the study (January 
1 to October 31, 2018). During the 
review of records, events were 
standardized to “respiratory, scours, 
navel, metaphylaxis and other.” Other 
included: bloat, joint-ill, pink eye, ear 
infection and arthritis. If multiple 
treatments were provided to the 
animal for the same bout of illness, it 
was considered one event (i.e., a five-
day treatment for a navel infection = 
one event). 
To standardize the treatment price 
across participating farms, costs were 
determined for each treatment based 
off the purchase price from Valley 
Veterinary Supply. A cost of individual 
treatment, and total treatment cost 
per calf was then calculated. It is 
important to note that only drug cost 
was included in the calculation of cost.
A total of 6,255 treatment records, 
from 2,618 non-lactating heifers were 
collected from eight Northern New 
York dairy farms between January 1 
and August 31, 2018. Average herd size 
was 1,836 mature cows with a range 
of 709 to 3,240. Average size of the 
heifer herd was 2,056 with a range 
from 810 to 3,006. In total, this study 
represents approximately 14,391 non-
lactating animals. Average herd size 
reported in this study is greater than 
many Northern New York herds. This 
is because all small farms that were 
contacted to participate in the study 
did not reach at least one of the three 
criteria.
A total of 5,732 (91.59 percent) 
of treatments were given to non-
lactating heifers, according to the 
written on-farm protocol. Compliance 
across herds ranged from 73.58 to 
100 percent. Protocol compliance was 
similar across treatment events and 
ranged from 90.03 percent compliance 
for pneumonia to 100 percent 
compliance for treatments categorized 
in other. Compliance to treatment 
protocols was very high in this study. 
It’s important to note that the farm 
that had 100 percent compliance was 
recording all events and treatments 
in Dairy Comp 305, and there were no 
written records. This observational 
study only compared records to 
protocols. We did not evaluate how 
accurate the records were on the 
farm (i.e., did the treatment record 
match what was actually provided to 
the calf?). It is also important to note 
that three farms did not report any 
treatment events for calves less than 31 
days of age.
Average age of treatment was 77 
days of age (range = 0 to 626; Table 
1). The largest number of calves 
were treated between eight to 31 
days, primarily scours, and 61 to 120, 
primarily scours (Figure 1). Only 14 
heifers were treated after 365 days of 
age, nine for pneumonia and five for 
“other.”  Treatment of navel infections 
occurred early in life, with an average 
of 12.19 days of age, but ranging from 
three to 73 days (Table 5). Scour 
treatments occurred within the first 
few months of life, with an average age 
of 13.05 days of age, but ranged from 0 
to 104 days.
Average treatment cost per event 
was $8.08 per animal, with a range 
of $0.09 to $34.28. Average total cost 
of treatment(s) per animal over the 
eight-month period was $18.17, with 
a range of $0.20 to $129.10. Average 
event treatment cost ranged from $1.12 
for scours ($0.35 to 29.12) and navel 
infections ($0.20 to $29.12), to $9.08 for 
pneumonia ($ 0.09 to $34.28) and $9.57 
for metaphylaxis ($0.489 to $9.79). It is 
important to note that for treatment 
cost we only evaluated the cost of the 
drug that was administered. We did 
not include costs associated with labor, 
supplies (needle, syringe, IV tube, etc.), 
lost future milk production, increased 
cost of heifer rearing related to losses 
in feed efficiency, growth rates, as well 
as costs related to developing carrier 
animals and risk of relapse.
Calves that received treatment were 
treated an average of 2.19 times over 
the eight-month period with a range of 
one to nine times.
CONCLUSION
The two greatest challenges with 
this project were identifying, and 
subsequently enrolling, farms that had 
written calf treatment protocols, and 
accurate calf treatment records that 
included: ID, date of treatment, reason 
treated, drug administered and dosage. 
Many farms did not have written calf 
treatment protocols. For those that 
did, many either did not keep calf 
treatment records or kept very minimal 
records that didn’t include necessary 
information. This is concerning from 
both an animal welfare and food safety 
standpoint. Without written treatment 
protocols, an employee may not know 
how to identify and properly treat 
an animal based on the symptoms 
observed. They may wait until another 
employee or manager is present. If the 
herdsman who normally treats calves is 
on vacation, the calf is left to suffer for 
the time being. This is an unacceptable 
practice and can easily be avoided. 
Written protocols should identify what 
to look for in the calf and the course 
of treatment. This should include what 
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antibiotic should be given (if any), the 
dosage, where to administer the shot, 
how often the shot should be given and 
the withdrawal time. The treatment 
protocol should also include who the 
employee contact should be if there is 
a question. If only certain people are 
allowed to treat animals, all employees 
should know who they are and how 
to contact them. Without written 
treatment records, it’s unknown as to 
what animal was treated. This can lead 
to an animal accidently being sent to 
slaughter with a residue. While the two 
aforementioned points are concerning, 
this study does demonstrate that with 
both written treatment protocols and 
written treatment records, protocol 
compliance is high.  ❚
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